miR-296
| miR-296 | |
|---|---|
 Conserved secondary structure of miR-296 microRNA precursor | |
| Identifiers | |
| Symbol | miR-296 |
| Alt. Symbols | MIR296 |
| Rfam | RF00733 |
| miRBase | MI0000747 |
| miRBase family | MIPF0000159 |
| Entrez | 407022 |
| HUGO | 31617 |
| OMIM | 610945 |
| RefSeq | NR_029844 |
| Other data | |
| RNA type | miRNA |
| Domain(s) | Mammalia |
| GO | 0035195 |
| SO | 0001244 |
| Locus | Chr. 20 q13.32 |
miR-296 is a family of microRNA precursors found in mammals, including humans. The ~22 nucleotide mature miRNA sequence is excised from the precursor hairpin by the enzyme Dicer.[1] This sequence then associates with RISC which effects RNA interference.[2]
miR-296 has been named an "angiomiR"[3] due to being characterised as a microRNA which regulates angiogenesis, the process of growth and creation of new blood vessels.[4] miR-296 is thought to have a specific role in cancer in promoting tumour angiogenesis.[3][5] It achieves this by targeting HGS mRNA, reducing its expression in endothelial cells which then results in greater number of VEGF receptors.[3][6]
miR-296 has predicted target sites in the transcription factor NANOG[7] and may also contribute to carcinogenesis by dysregulating p53.[8]
References
- ↑ Ambros, V (2001-12-28). "microRNAs: tiny regulators with great potential.". Cell. 107 (7): 823–6. PMID 11779458. doi:10.1016/S0092-8674(01)00616-X.
- ↑ Gregory, RI; Chendrimada, TP; Cooch, N; Shiekhattar, R (2005-11-18). "Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.". Cell. 123 (4): 631–40. PMID 16271387. doi:10.1016/j.cell.2005.10.022.
- 1 2 3 Wang, S; Olson, EN (June 2009). "AngiomiRs--key regulators of angiogenesis". Current Opinion in Genetics & Development. 19 (3): 205–11. PMC 2696563
. PMID 19446450. doi:10.1016/j.gde.2009.04.002. - ↑ Anand, S; Cheresh, DA (May 2011). "MicroRNA-mediated regulation of the angiogenic switch". Current Opinion in Hematology. 18 (3): 171–6. PMC 3159578 . PMID 21423013. doi:10.1097/MOH.0b013e328345a180. (subscription required)
- ↑ Bonauer, A; Boon, RA; Dimmeler, S (August 2010). "Vascular microRNAs". Current drug targets. 11 (8): 943–9. PMID 20415654. doi:10.2174/138945010791591313.
- ↑ Würdinger, T; Tannous, BA; Saydam, O; Skog, J; Grau, S; Soutschek, J; Weissleder, R; Breakefield, XO; Krichevsky, AM (2008-11-04). "miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells". Cancer Cell. 14 (5): 382–93. PMC 2597164 . PMID 18977327. doi:10.1016/j.ccr.2008.10.005.
- ↑ Tay, Y; Zhang, J; Thomson, AM; Lim, B; Rigoutsos, I (2008-10-23). "MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation". Nature. 455 (7216): 1124–8. PMID 18806776. doi:10.1038/nature07299.
- ↑ Yoon, AR; Gao, R; Kaul, Z; Choi, IK; Ryu, J; Noble, JR; Kato, Y; Saito, S; Hirano, T; Ishii, T; Reddel, RR; Yun, CO; Kaul, SC; Wadhwa, R (2011-06-30). "MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region". Nucleic Acids Research. 39 (18): 8078–91. PMC 3185413 . PMID 21724611. doi:10.1093/nar/gkr492.